Drug intelligence / Profile preview

alpha lipoic acid + inositol

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Alpha lipoic acid + inositol is a combination dietary supplement composed of two bioactive compounds frequently used together to address metabolic and endocrine disorders. In this combination: - **Inositol** (primarily as myo-inositol or D-chiro-inositol) acts as an insulin sensitizer by functioning as a second messenger for insulin signaling pathways, thereby improving glucose metabolism and reducing insulin resistance. - **Alpha lipoic acid (ALA)** is a potent antioxidant that serves as a cofactor for mitochondrial dehydrogenase complexes. It enhances glucose uptake into cells and further improves insulin sensitivity while also reducing oxidative stress. This combination has been studied primarily for its effects on metabolic syndrome and polycystic ovary syndrome (PCOS), where it has demonstrated benefits such as improved menstrual cyclicity, ovulation rates, reduced hyperinsulinemia, better lipid profiles (increased HDL cholesterol; decreased triglycerides), lower HOMA-IR index values (a measure of insulin resistance), reduced body mass index (BMI), waist circumference reduction, and improved liver enzyme profiles. The synergistic action of these agents makes the combination particularly promising for women with PCOS—especially those who are overweight/obese or have familial diabetes—and individuals with features of metabolic syndrome[1][2][3][4][6][7].

Other names
ALA + inositolalpha-lipoic acid and inositolALA plus inositolmyo-inositol + alpha-lipoic acidD-chiro-inositol + alpha-lipoic acid

Beyond the preview

Go deeper on alpha lipoic acid + inositol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha lipoic acid + inositol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call